Alpha 2.0
Login Register
» Articles » PMID: 9690412

Anaemia in Dialysis Patients As a Side-effect of Sartanes

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1998 Aug 5
PMID 9690412
Citations 10
Authors
A Schwarzbeck
K W Wittenmeier
U Hallfritzsch
Affiliations
Soon will be listed here.
Citing Articles

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases.

Liu Q, Cui Z, Deng C, Yang C, Shi T Front Pharmacol. 2024; 15:1485190.

PMID: 39635439 PMC: 11614654. DOI: 10.3389/fphar.2024.1485190.

High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis.

Fang Y, Wang J, Lin T, Lee C, Jang T, Tsai M Front Med (Lausanne). 2023; 10:1098871.

PMID: 37081846 PMC: 10110852. DOI: 10.3389/fmed.2023.1098871.

Relationship between anti-erythropoietin receptor autoantibodies and responsiveness to erythropoiesis-stimulating agents in patients on hemodialysis: a multi-center cross-sectional study.

Hara A, Koshino Y, Kurokawa Y, Shinozaki Y, Miyake T, Kitajima S Clin Exp Nephrol. 2019; 24(1):88-95.

PMID: 31502102 DOI: 10.1007/s10157-019-01787-6.

The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.

An J, Hwang J, Lee J, Chin H, Kim S, Kim D PLoS One. 2015; 10(6):e0128632.

PMID: 26098847 PMC: 4476682. DOI: 10.1371/journal.pone.0128632.

Antihypertensive medications and anemia.

Sica D, Mannino R J Clin Hypertens (Greenwich). 2007; 9(9):723-7.

PMID: 17786076 PMC: 8110062. DOI: 10.1111/j.1524-6175.2007.06296.x.